نوع مقاله : اصیل پژوهشی
نویسندگان
1 استاد گروه زنان و مامایی، دانشکده پزشکی، دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران.
2 دستیار گروه زنان و مامایی، دانشکده پزشکی، دانشگاه علوم پزشکی شهید بهشتی، تهران، ایران.
چکیده
کلیدواژهها
موضوعات
عنوان مقاله [English]
نویسندگان [English]
Introduction: Considering the importance and relatively high prevalence of cases of threatened abortion and the fact that there is still no completely proven preventive method for this disorder that are mostly associated with many complications, this study was conducted with aim to compare pregnancy continuation rates and the efficacy of vaginal progesterone versus oral dydrogesterone in threatened miscarriage.
Methods: This semi-experimental study was conducted in 2022-2024 on 62 pregnant women with threatened miscarriage referred to Ayatollah Taleghani and Imam Hossein (AS) Hospitals in Tehran. Participants were allocated into two comparative groups: one receiving oral dydrogesterone and the other administered vaginal progesterone suppositories. Vaginal bleeding duration, bleeding volume, miscarriage rates, drug-related adverse effects, and serum progesterone levels were compared between the two groups. Data analysis was performed using SPSS software (version 25) and Chi-square test. P<0.05 was considered significant.
Results: In women of the oral dydrogesterone group compared to the progesterone suppository group, the duration of vaginal bleeding after the study (6.26 ± 2.58 vs. 10.68 ± 5.29 days, P<0.001), Prevalence of miscarriage (16.1 vs. 38.7%, P=0.046) and non-continuation of pregnancy (19.4 vs. 54.8%, P=0.004) was significantly lower and the percentage of satisfaction was higher (22.6 vs. 3.2%, P<0.001).
Conclusion: Due to high effectiveness, proper access, very limited side effects and high satisfaction, administration of oral dydrogesterone in cases of threatened abortion is more preferable than vaginal form of progesterone.
کلیدواژهها [English]